The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Return of Chloroquine Antimalarial Efficacy in Malawi
Open accessAbstract
BACKGROUND: In 1993, Malawi became the first country in Africa to replace chloroquine with the combination of sulfadoxine and pyrimethamine for the treatment of malaria. At that time, the clinical efficacy of chloroquine was less than 50%. The molecular marker of chloroquine-resistant falciparum malaria subsequently declined in prevalence and was undetectable by 2001, suggesting that chloroquine might once again be effective in Malawi. METHODS: We conducted a randomized clinical trial involving 210 children with uncomplicated Plasmodium falciparum malaria in Blantyre, Malawi. The children were treated with either chloroquine or sulfadoxine\#8211;pyrimethamine and followed for 28 days to assess the antimalarial efficacy of the drug. RESULTS: In analyses conducted according to the study protocol, treatment failure occurred in 1 of 80 participants assigned to chloroquine, as compared with 71 of 87 participants assigned to sulfadoxine\#8211;pyrimethamine. The cumulative efficacy of chloroquine was 99% (95% confidence interval [CI], 93 to 100), and the efficacy of sulfadoxine\#8211;pyrimethamine was 21% (95% CI, 13 to 30). Among children treated with chloroquine, the mean time to parasite clearance was 2.6 days (95% CI, 2.5 to 2.8) and the mean time to the resolution of fever was 10.3 hours (95% CI, 8.1 to 12.6). No unexpected adverse events related to the study drugs occurred. CONCLUSIONS: Chloroquine is again an efficacious treatment for malaria, 12 years after it was withdrawn from use in Malawi. (ClinicalTrials.gov number, NCT00125489 [ClinicalTrials.gov].).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Molecular Marker for Chloroquine-Resistant Falciparum Malaria
Djimdé, A., Doumbo, O. K., Cortese, J. F., Kayentao, K., Doumbo, S., Diourté, Y., Coulibaly, D., Dicko, A., Su, X.-Z., Nomura, T., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101253440403 · Cited by 1,010
Self-citationWellems, T. E., & Plowe, C. V. (2001) · The Journal of Infectious Diseases · doi:10.1086/322858 · Cited by 807
Self-citationAnderson, T. J. C., Haubold, B., Williams, J. T., Estrada-Franco§, J. G., Richardson, L., Mollinedo, R., Bockarie, M., Mokili, J., Mharakurwa, S., French, N., et al. (2000) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a026247 · Cited by 779
Plowe, C. V., Djimde, A., Bouare, M., Doumbo, O., & Wellems, T. E. (1995) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1995.52.565 · Cited by 674
Self-citationKublin, J. G., Cortese, J. F., Njunju, E. M., G. Mukadam, R. A., Wirima, J. J., Kazembe, P. N., Djimdé, A. A., Kouriba, B., Taylor, T. E., & Plowe, C. V. (2003) · The Journal of Infectious Diseases · doi:10.1086/375419 · Cited by 508
Self-citationBloland, P. B., Ringwald, P., & Snow, R. W. (2003) · Cited by 499
Shulman, C., Dorman, E., Cutts, F., Kawuondo, K., Bulmer, J., Peshu, N., & Marsh, K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07318-8 · Cited by 386
Schellenberg, D., Menendez, C., Kahigwa, E., Aponte, J., Vidal, J., Tanner, M., Mshinda, H., & Alonso, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04643-2 · Cited by 328
Bloland, P. B., Lackritz, E. M., Kazembe, P. N., Were, J. B. O., Steketee, R., & Campbell, C. C. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.4.932 · Cited by 287
Cissé, B., Sokhna, C., Boulanger, D., Milet, J., Bâ, E. H., Richardson, K., Hallett, R., Sutherland, C., Simondon, K., Simondon, F., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68264-0 · Cited by 209
Cited by
Artemisinin resistance: current status and scenarios for containment
Dondorp, A. M., Yeung, S., White, L., Nguon, C., Day, N. P. J., Socheat, D., & von Seidlein, L. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2331 · Cited by 645
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria
Eastman, R. T., & Fidock, D. A. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2239 · Cited by 568
Antimalarial drug resistance in Africa: the calm before the storm?
Conrad, M. D., & Rosenthal, P. J. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30261-0 · Cited by 255
Clerk, C. A., Bruce, J., Affipunguh, P. K., Mensah, N., Hodgson, A., Greenwood, B., & Chandramohan, D. (2008) · The Journal of Infectious Diseases · doi:10.1086/591944 · Cited by 65
McGready, R., White, N., & Nosten, F. (2011) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02810.x · Cited by 54
Metadata
- Authors
- Laufer, M. K., Thesing, P. C., Eddington, N. D., Masonga, R., Dzinjalamala, F. K., Takala, S. L., Taylor, T. E., & Plowe, C. V.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-11-09
- Volume
- 355
- Issue
- 19
- Pages
- 1959-1966
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1999748946
- Cited by
- 432
- References
- 21
- FWCI
- 27.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Return of Chloroquine Antimalarial Efficacy in Malawi. https://app.cochat.ai/papers/10.1056/nejmoa062032
- The paper
- Laufer, M. K., Thesing, P. C., Eddington, N. D., Masonga, R., Dzinjalamala, F. K., Takala, S. L., Taylor, T. E., & Plowe, C. V. (2006). Return of Chloroquine Antimalarial Efficacy in Malawi. New England Journal of Medicine. https://doi.org/10.1056/nejmoa062032
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.